Relationship between Methylation Status of Multi-drug Resistance Protein (MRP) and Multi-drug Resistance in Lung Cancer Cell Lines

被引:0
|
作者
Li, Hong [2 ]
Zhu, Yi-Fei [1 ]
Zheng, Shi-Ying [1 ]
Jiang, Dong [1 ]
机构
[1] Suzhou Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou 215006, Jiangsu Prov, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou 215006, Jiangsu Prov, Peoples R China
关键词
Lung cancer; Multi-drug resistance protein(MRP); Methylation Multi-drug resistance(MDR); CPG HYPERMETHYLATION; PROSTATE-CANCER; PROMOTER REGION; GENE; ALPHA;
D O I
10.1109/FBIE.2009.5405779
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To study the relationship between the methylation status of multi-drug resistance protein (MRP) gene and the expression of its mRNA and protein in lung cancer cell lines. Methods:Human lung cell line WI-38.lung adenocarcinoma cell line SPCA-1 and its drug-resistant cells induced by different concentrations of doxorubicin were treated with restriction endonuclease Eco47III.The methylation status of MRP was examined by PCR,and the expressions of its mRNA and protein were evaluated by in situ hybridization and immunohistochemistry. Resuits: MRP gene promoter region of WI-38 cells was in hypermethylation status.but the promoter region of MRP in SPCA-1 cells and their resistant derivatives induced by different concentrations of doxorubicin were in hypomethylation status.There were Significant differences in the expression of MRP mRNA among WI-38 cell line.SPCA-1 cells and their drug-resistan t derivatives induced by different con- centration of doxorubicin.Consistently.MRP immunostaining presented similar significant differences. Conclusion:The promoter region of MRP in SPCA-1 lung adenocarcinoma cells was in hypomethylation status. The hypomethylation status of regulatory region of MRP promoter is an important structural basis that can increase the activity of transcrip-tion and results in the development of drug resistan cc in lung cancer.
引用
收藏
页码:548 / +
页数:2
相关论文
共 50 条
  • [31] Deciphering the metabolic role of AMPK in cancer multi-drug resistance
    Tan, Wen
    Zhong, Zhangfeng
    Carney, Randy P.
    Men, Yongfan
    Li, Jiannan
    Pan, Tingrui
    Wang, Yitao
    SEMINARS IN CANCER BIOLOGY, 2019, 56 : 56 - 71
  • [32] Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer
    Huang, Dabing
    Wang, Yong
    He, Yifu
    Wang, Gang
    Wang, Wei
    Han, Xinghua
    Sun, Yubei
    Lin, Lin
    Shan, Benjie
    Shen, Guodong
    Cheng, Min
    Bian, Geng
    Fang, Xiang
    Hu, Shilian
    Pan, Yueyin
    CANCER CELL INTERNATIONAL, 2018, 18
  • [33] Systematic functional identification of cancer multi-drug resistance genes
    Man-Tat Lau
    Shila Ghazanfar
    Ashleigh Parkin
    Angela Chou
    Jourdin R. Rouaen
    Jamie B. Littleboy
    Danielle Nessem
    Thang M. Khuong
    Damien Nevoltris
    Peter Schofield
    David Langley
    Daniel Christ
    Jean Yang
    Marina Pajic
    G. Gregory Neely
    Genome Biology, 21
  • [34] Systematic functional identification of cancer multi-drug resistance genes
    Lau, Man-Tat
    Ghazanfar, Shila
    Parkin, Ashleigh
    Chou, Angela
    Rouaen, Jourdin R.
    Littleboy, Jamie B.
    Nessem, Danielle
    Khuong, Thang M.
    Nevoltris, Damien
    Schofield, Peter
    Langley, David
    Christ, Daniel
    Yang, Jean
    Pajic, Marina
    Neely, G. Gregory
    GENOME BIOLOGY, 2020, 21 (01)
  • [35] Recent developments in overcoming tumour cell multi-drug resistance
    Ecker, G
    Chiba, P
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (06) : 589 - 599
  • [36] Expression and significance of multi-drug resistance-associated protein 3 in different tumor cell lines
    张辉
    高玮
    王从俊
    尤天庚
    ChinaMedicalAbstracts(Surgery), 2010, 19 (01) : 59 - 62
  • [37] Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
    Wu, Qiong
    Yang, Zhiping
    Nie, Yongzhan
    Shi, Yongquan
    Fan, Daiming
    CANCER LETTERS, 2014, 347 (02) : 159 - 166
  • [38] Novel cell lines from pediatric brain tumors show multi-drug resistance
    Xu, Jingying
    Gonzalez-Gomez, Ignacio
    Melendez, Elizabeth Y.
    Moats, Rex A.
    Erdreich-Epstein, Anat
    Reynolds, C. Patrick
    NEURO-ONCOLOGY, 2006, 8 (04) : 470 - 470
  • [39] Nutritional status in multi-drug resistance-pulmonary tuberculosis patients
    Kumar, Amit
    Kakkar, Rakesh
    Kandpal, S. D.
    Sindhwani, Girish
    INDIAN JOURNAL OF COMMUNITY HEALTH, 2014, 26 : 204 - 208
  • [40] Effectiveness of partial lung resection at multi-drug resistance of tuberculosis mycobacteria
    Sabirov, Shavkat
    Kariev, Tulkun
    Irgashev, Akram
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40